These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
893 related items for PubMed ID: 26964154
1. Diagnostic Performance of Positron Emission Tomography for the Presurgical Evaluation of Patients with Non-lesional Intractable Partial Epilepsy: Comparison among 18F-FDG, 11C-Flumazenil, and 11C-Flumazenil Binding Potential Imaging Using Statistical Imaging Analysis. Komoto D, Iida K, Higaki T, Kaichi Y, Takauchi K, Arihiro K, Kakita A, Hirokawa Y, Awai K. Hiroshima J Med Sci; 2015 Dec; 64(4):51-7. PubMed ID: 26964154 [Abstract] [Full Text] [Related]
2. Positron emission tomography in presurgical localization of epileptic foci. Csaba J. Ideggyogy Sz; 2003 Jul 20; 56(7-8):249-54. PubMed ID: 12971120 [Abstract] [Full Text] [Related]
4. Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Ryvlin P, Bouvard S, Le Bars D, De Lamérie G, Grégoire MC, Kahane P, Froment JC, Mauguière F. Brain; 1998 Nov 20; 121 ( Pt 11)():2067-81. PubMed ID: 9827767 [Abstract] [Full Text] [Related]
5. 18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy. Vivash L, Gregoire MC, Lau EW, Ware RE, Binns D, Roselt P, Bouilleret V, Myers DE, Cook MJ, Hicks RJ, O'Brien TJ. J Nucl Med; 2013 Aug 20; 54(8):1270-7. PubMed ID: 23857513 [Abstract] [Full Text] [Related]
8. Advanced [(18)F]FDG and [(11)C]flumazenil PET analysis for individual outcome prediction after temporal lobe epilepsy surgery for hippocampal sclerosis. Yankam Njiwa J, Gray KR, Costes N, Mauguiere F, Ryvlin P, Hammers A. Neuroimage Clin; 2015 Aug 20; 7():122-31. PubMed ID: 25610774 [Abstract] [Full Text] [Related]
9. Can we increase the yield of FDG-PET in the preoperative work-up for epilepsy surgery? van't Klooster MA, Huiskamp G, Zijlmans M, Debets RM, Comans EF, Bouvard S, Ryvlin P, Leijten FS. Epilepsy Res; 2014 Aug 20; 108(6):1095-105. PubMed ID: 24893829 [Abstract] [Full Text] [Related]
12. Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy. Juhász C, Nagy F, Watson C, da Silva EA, Muzik O, Chugani DC, Shah J, Chugani HT. Neurology; 1999 Dec 10; 53(9):2037-45. PubMed ID: 10599778 [Abstract] [Full Text] [Related]
13. Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome. Juhász C, Chugani DC, Muzik O, Shah A, Shah J, Watson C, Canady A, Chugani HT. Neurology; 2001 Jun 26; 56(12):1650-8. PubMed ID: 11425929 [Abstract] [Full Text] [Related]
14. Voxel- and ROI-based statistical analyses of PET parameters for guidance in the surgical treatment of intractable mesial temporal lobe epilepsy. Ohta Y, Nariai T, Ishii K, Ishiwata K, Mishina M, Senda M, Hirakawa K, Ohno K. Ann Nucl Med; 2008 Jul 26; 22(6):495-503. PubMed ID: 18670856 [Abstract] [Full Text] [Related]
15. [11C]Flumazenil PET in patients with epilepsy with dual pathology. Juhász C, Nagy F, Muzik O, Watson C, Shah J, Chugani HT. Epilepsia; 1999 May 26; 40(5):566-74. PubMed ID: 10386525 [Abstract] [Full Text] [Related]
17. Positron emission tomography in partial epilepsies: the clinical point of view. Koutroumanidis M, Binnie CD, Panayiotopoulos CP. Nucl Med Commun; 1998 Dec 26; 19(12):1123-6. PubMed ID: 9885801 [Abstract] [Full Text] [Related]